{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:20:52Z","timestamp":1790828452933,"version":"4.1.0"},"reference-count":84,"publisher":"e-Century Publishing Corporation","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/avym3477","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T05:19:27Z","timestamp":1728364767000},"page":"4652-4664","source":"Crossref","is-referenced-by-count":10,"title":["ZIP4: a promising early diagnostic and therapeutic targets for pancreatic cancer"],"prefix":"10.62347","volume":"14","author":[{"given":"Yunpeng","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","article-title":"The enhancement of glycolysis regulates pancreatic cancer metastasis","volume":"77","author":"Yang","year":"2020","unstructured":"Yang J, Ren B, Yang G, Wang H, Chen G, You L, Zhang T and Zhao Y. The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci 2020; 77: 305-321.","journal-title":"Cell Mol Life Sci"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE and Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021; 71: 7-33.","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.20892\/j.issn.2095-3941.2020.0106","article-title":"Zinc dysregulation in cancers and its potential as a therapeutic target","volume":"17","author":"Wang","year":"2020","unstructured":"Wang J, Zhao H, Xu Z and Cheng X. Zinc dysregulation in cancers and its potential as a therapeutic target. Cancer Biol Med 2020; 17: 612-625.","journal-title":"Cancer Biol Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"24085","DOI":"10.1074\/jbc.R600011200","article-title":"Mammalian zinc transport, trafficking, and signals","volume":"281","author":"RJ","year":"2006","unstructured":"Cousins RJ, Liuzzi JP and Lichten LA. Mammalian zinc transport, trafficking, and signals. J Biol Chem 2006; 281: 24085-24089.","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"18636","DOI":"10.1073\/pnas.0709307104","article-title":"Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression","volume":"104","author":"Li","year":"2007","unstructured":"Li M, Zhang Y, Liu Z, Bharadwaj U, Wang H, Wang X, Zhang S, Liuzzi JP, Chang SM, Cousins RJ, Fisher WE, Brunicardi FC, Logsdon CD, Chen C and Yao Q. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A 2007; 104: 18636-18641.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","unstructured":"Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE, Kuick R and Hanash S. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003; 63: 2649-2657."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Yang J, Zhang Y, Cui X, Yao W, Yu X, Cen P, Hodges SE, Fisher WE, Brunicardi FC, Chen C, Yao Q and Li M. Gene profile identifies zinc transporters differentially expressed in normal human organs and human pancreatic cancer. Curr Mol Med 2013; 13: 401-409.","DOI":"10.2174\/1566524011313030009"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1111\/cas.13737","article-title":"Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer","volume":"109","author":"Jin","year":"2018","unstructured":"Jin H, Liu P, Wu Y, Meng X, Wu M, Han J and Tan X. Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer. Cancer Sci 2018; 109: 2946-2956.","journal-title":"Cancer Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1074\/jbc.M610552200","article-title":"A histidine-rich cluster mediates the ubiquitination and degradation of the human zinc transporter, hZIP4, and protects against zinc cytotoxicity","volume":"282","author":"Mao","year":"2007","unstructured":"Mao X, Kim BE, Wang F, Eide DJ and Petris MJ. A histidine-rich cluster mediates the ubiquitination and degradation of the human zinc transporter, hZIP4, and protects against zinc cytotoxicity. J Biol Chem 2007; 282: 6992-7000.","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1086\/341125","article-title":"A novel member of a zinc transporter family is defective in acrodermatitis enteropathica","volume":"71","author":"Wang","year":"2002","unstructured":"Wang K, Zhou B, Kuo YM, Zemansky J and Gitschier J. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am J Hum Genet 2002; 71: 66-73.","journal-title":"Am J Hum Genet"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"MacDonald RS. The role of zinc in growth and cell proliferation. J Nutr 2000; 130 Suppl: 1500S-1508S.","DOI":"10.1093\/jn\/130.5.1500S"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bone.2005.08.010","article-title":"Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells","volume":"38","author":"Tang","year":"2006","unstructured":"Tang Z, Sahu SN, Khadeer MA, Bai G, Franklin RB and Gupta A. Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells. Bone 2006; 38: 181-198.","journal-title":"Bone"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1046\/j.1365-2036.2003.01738.x","article-title":"Expression of carbonic anhydrase IX in human pancreatic cancer","volume":"18","author":"Juh&#xE1","year":"2003","unstructured":"Juh&#xE1;sz M, Chen J, Lendeckel U, Kellner U, Kasper HU, Tulassay Z, Pastorekova S, Malfertheiner P and Ebert MP. Expression of carbonic anhydrase IX in human pancreatic cancer. Aliment Pharmacol Ther 2003; 18: 837-846.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/j.1445-2197.2006.03872.x","article-title":"Hypoxia and angiogenesis in pancreatic cancer","volume":"76","author":"Garcea","year":"2006","unstructured":"Garcea G, Doucas H, Steward WP, Dennison AR and Berry DP. Hypoxia and angiogenesis in pancreatic cancer. ANZ J Surg 2006; 76: 830-842.","journal-title":"ANZ J Surg"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1074\/jbc.M310799200","article-title":"Zn2+-stimulated endocytosis of the mZIP4 zinc transporter regulates its location at the plasma membrane","volume":"279","author":"Kim","year":"2004","unstructured":"Kim BE, Wang F, Dufner-Beattie J, Andrews GK, Eide DJ and Petris MJ. Zn2+-stimulated endocytosis of the mZIP4 zinc transporter regulates its location at the plasma membrane. J Biol Chem 2004; 279: 4523-4530.","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.nutr.24.012003.132402","article-title":"Mammalian zinc transporters","volume":"24","author":"Liuzzi","year":"2004","unstructured":"Liuzzi JP and Cousins RJ. Mammalian zinc transporters. Annu Rev Nutr 2004; 24: 151-172.","journal-title":"Annu Rev Nutr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s00424-003-1074-3","article-title":"The SLC39 family of metal ion transporters","volume":"447","author":"Eide","year":"2004","unstructured":"Eide DJ. The SLC39 family of metal ion transporters. Pflugers Arch 2004; 447: 796-800.","journal-title":"Pflugers Arch"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1476-4598-5-17","article-title":"The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots","volume":"5","author":"Costello","year":"2006","unstructured":"Costello LC and Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 2006; 5: 17.","journal-title":"Mol Cancer"},{"key":"ref18","unstructured":"Chakravarty PK, Ghosh A and Chowdhury JR. Zinc in human malignancies. Neoplasma 1986; 33: 85-90."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/1097-0142(19830901)52:5<868::AID-CNCR2820520521>3.0.CO;2-K","article-title":"Copper and zinc levels in normal and malignant tissues","volume":"52","author":"EJ","year":"1983","unstructured":"Margalioth EJ, Schenker JG and Chevion M. Copper and zinc levels in normal and malignant tissues. Cancer 1983; 52: 868-872.","journal-title":"Cancer"},{"key":"ref20","unstructured":"Mulay IL, Roy R, Knox BE, Suhr NH and Delaney WE. Trace-metal analysis of cancerous and noncancerous human tissues. J Natl Cancer Inst 1971; 47: 1-13."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1042\/bj20030478","article-title":"Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters","volume":"375","author":"Taylor","year":"2003","unstructured":"Taylor KM, Morgan HE, Johnson A, Hadley LJ and Nicholson RI. Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters. Biochem J 2003; 375: 51-59.","journal-title":"Biochem J"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1349-7006.2007.00446.x","article-title":"Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells","volume":"98","author":"Kagara","year":"2007","unstructured":"Kagara N, Tanaka N, Noguchi S and Hirano T. Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells. Cancer Sci 2007; 98: 692-697.","journal-title":"Cancer Sci"},{"key":"ref23","unstructured":"Lee R, Woo W, Wu B, Kummer A, Duminy H and Xu Z. Zinc accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors is accompanied by an altered expression of ZnT-1 and metallothionein. Exp Biol Med (Maywood) 2003; 228: 689-696."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"5993","DOI":"10.1158\/1078-0432.CCR-09-0557","article-title":"Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts","volume":"15","author":"Li","year":"2009","unstructured":"Li M, Zhang Y, Bharadwaj U, Zhai QJ, Ahern CH, Fisher WE, Brunicardi FC, Logsdon CD, Chen C and Yao Q. Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res 2009; 15: 5993-6001.","journal-title":"Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/emmm.201302507","article-title":"A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth","volume":"5","author":"Zhang","year":"2013","unstructured":"Zhang Y, Yang J, Cui X, Chen Y, Zhu VF, Hagan JP, Wang H, Yu X, Hodges SE, Fang J, Chiao PJ, Logsdon CD, Fisher WE, Brunicardi FC, Chen C, Yao Q, Fernandez-Zapico ME and Li M. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. EMBO Mol Med 2013; 5: 1322-1334.","journal-title":"EMBO Mol Med"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Shi X, Yang J, Liu M, Zhang Y, Zhou Z, Luo W, Fung KM, Xu C, Bronze MS, Houchen CW and Li M. Circular RNA ANAPC7 inhibits tumor growth and muscle wasting via PHLPP2-AKT-TGF-&#x3B2; signaling axis in pancreatic cancer. Gastroenterology 2022; 162: 2004-2017, e2002.","DOI":"10.1053\/j.gastro.2022.02.017"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.4161\/cc.28111","article-title":"ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer","volume":"13","author":"Cui","year":"2014","unstructured":"Cui X, Zhang Y, Yang J, Sun X, Hagan JP, Guha S and Li M. ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer. Cell Cycle 2014; 13: 1180-1186.","journal-title":"Cell Cycle"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1071553","article-title":"The Fas signaling pathway: more than a paradigm","volume":"296","author":"Wajant","year":"2002","unstructured":"Wajant H. The Fas signaling pathway: more than a paradigm. Science 2002; 296: 1635-1636.","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/17135","article-title":"Molecular characterization of mitochondrial apoptosis-inducing factor","volume":"397","author":"Susin","year":"1999","unstructured":"Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM and Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-446.","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1476-4598-2-6","article-title":"Apoptosis: targets in pancreatic cancer","volume":"2","author":"Westphal","year":"2003","unstructured":"Westphal S and Kalthoff H. Apoptosis: targets in pancreatic cancer. Mol Cancer 2003; 2: 6.","journal-title":"Mol Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/cas.16124","article-title":"Serum and tissue metallome of pancreatic ductal adenocarcinoma","volume":"115","author":"Byeon","year":"2024","unstructured":"Byeon S, du Toit-Thompson T, Hipperson L, Maloney S, Wenzel R, Gill AJ, Samra JS, Mittal A and Sahni S. Serum and tissue metallome of pancreatic ductal adenocarcinoma. Cancer Sci 2024; 115: 1446-1458.","journal-title":"Cancer Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/ncb3340","article-title":"Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis","volume":"18","author":"Nielsen","year":"2016","unstructured":"Nielsen SR, Quaranta V, Linford A, Emeagi P, Rainer C, Santos A, Ireland L, Sakai T, Sakai K, Kim YS, Engle D, Campbell F, Palmer D, Ko JH, Tuveson DA, Hirsch E, Mielgo A and Schmid MC. Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis. Nat Cell Biol 2016; 18: 549-560.","journal-title":"Nat Cell Biol"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Konstantinidis IT, Warshaw AL, Allen JN, Blaszkowsky LS, Castillo CF, Deshpande V, Hong TS, Kwak EL, Lauwers GY, Ryan DP, Wargo JA, Lillemoe KD and Ferrone CR. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a &#x201C;true&#x201D; R0 resection? Ann Surg 2013; 257: 731-736.","DOI":"10.1097\/SLA.0b013e318263da2f"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/jnci\/92.21.1717","article-title":"Metastasis-suppressor genes: a review and perspective on an emerging field","volume":"92","author":"Yoshida","year":"2000","unstructured":"Yoshida BA, Sokoloff MM, Welch DR and Rinker-Schaeffer CW. Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst 2000; 92: 1717-1730.","journal-title":"J Natl Cancer Inst"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.semcdb.2014.09.008","article-title":"The role of tight junctions in cancer metastasis","volume":"36","author":"Martin","year":"2014","unstructured":"Martin TA. The role of tight junctions in cancer metastasis. Semin Cell Dev Biol 2014; 36: 224-231.","journal-title":"Semin Cell Dev Biol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"18148","DOI":"10.3390\/ijms140918148","article-title":"Emerging roles of claudins in human cancer","volume":"14","author":"Kwon","year":"2013","unstructured":"Kwon MJ. Emerging roles of claudins in human cancer. Int J Mol Sci 2013; 14: 18148-18180.","journal-title":"Int J Mol Sci"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Miyoshi Y, Tanabe S and Suzuki T. Cellular zinc is required for intestinal epithelial barrier maintenance via the regulation of claudin-3 and occludin expression. Am J Physiol Gastrointest Liver Physiol 2016; 311: G105-116.","DOI":"10.1152\/ajpgi.00405.2015"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1158\/1078-0432.CCR-18-0263","article-title":"ZIP4 promotes pancreatic cancer progression by repressing ZO-1 and Claudin-1 through a ZEB1-dependent transcriptional mechanism","volume":"24","author":"Liu","year":"2018","unstructured":"Liu M, Yang J, Zhang Y, Zhou Z, Cui X, Zhang L, Fung KM, Zheng W, Allard FD, Yee EU, Ding K, Wu H, Liang Z, Zheng L, Fernandez-Zapico ME, Li YP, Bronze MS, Morris KT, Postier RG, Houchen CW, Yang J and Li M. ZIP4 promotes pancreatic cancer progression by repressing ZO-1 and Claudin-1 through a ZEB1-dependent transcriptional mechanism. Clin Cancer Res 2018; 24: 3186-3196.","journal-title":"Clin Cancer Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and definitions for research on epithelial-mesenchymal transition","volume":"21","author":"Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G, Dedhar S, Derynck R, Ford HL, Fuxe J, Garc&#xED;a de Herreros A, Goodall GJ, Hadjantonakis AK, Huang RYJ, Kalcheim C, Kalluri R, Kang Y, Khew-Goodall Y, Levine H, Liu J, Longmore GD, Mani SA, Massagu&#xE9; J, Mayor R, McClay D, Mostov KE, Newgreen DF, Nieto MA, Puisieux A, Runyan R, Savagner P, Stanger B, Stemmler MP, Takahashi Y, Takeichi M, Theveneau E, Thiery JP, Thompson EW, Weinberg RA, Williams ED, Xing J, Zhou BP and Sheng G; EMT International Association (TEMTIA). Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2020; 21: 341-352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12885-016-2117-4","article-title":"Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT","volume":"16","author":"Ti&#xE8","year":"2016","unstructured":"Ti&#xE8;che CC, Peng RW, Dorn P, Froment L, Schmid RA and Marti TM. Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT. BMC Cancer 2016; 16: 125.","journal-title":"BMC Cancer"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"10498","DOI":"10.1038\/ncomms10498","article-title":"ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types","volume":"7","author":"Lehmann","year":"2016","unstructured":"Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, Herr R, Brabletz S, Stemmler MP and Brabletz T. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat Commun 2016; 7: 10498.","journal-title":"Nat Commun"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Rosmaninho P, M&#xFC;kusch S, Piscopo V, Teixeira V, Raposo AA, Warta R, Bennewitz R, Tang Y, Herold-Mende C, Stifani S, Momma S and Castro DS. Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion. EMBO J 2018; 37: e97115.","DOI":"10.15252\/embj.201797115"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nsmb924","article-title":"CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain","volume":"12","author":"Kim","year":"2005","unstructured":"Kim JH, Cho EJ, Kim ST and Youn HD. CtBP represses p300-mediated transcriptional activation by direct association with its bromodomain. Nat Struct Mol Biol 2005; 12: 423-428.","journal-title":"Nat Struct Mol Biol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the roots of cancer","volume":"29","author":"Zanconato","year":"2016","unstructured":"Zanconato F, Cordenonsi M and Piccolo S. YAP\/TAZ at the roots of cancer. Cancer Cell 2016; 29: 783-803.","journal-title":"Cancer Cell"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1038\/s41467-019-10729-5","article-title":"Switch-like enhancement of epithelial-mesenchymal transition by YAP through feedback regulation of WT1 and Rho-family GTPases","volume":"10","author":"Park","year":"2019","unstructured":"Park J, Kim DH, Shah SR, Kim HN, Kshitiz, Kim P, Qui&#xF1;ones-Hinojosa A and Levchenko A. Switch-like enhancement of epithelial-mesenchymal transition by YAP through feedback regulation of WT1 and Rho-family GTPases. Nat Commun 2019; 10: 2797.","journal-title":"Nat Commun"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"15321","DOI":"10.1038\/ncomms15321","article-title":"YAP regulates cell mechanics by controlling focal adhesion assembly","volume":"8","author":"Nardone","year":"2017","unstructured":"Nardone G, Oliver-De La Cruz J, Vrbsky J, Martini C, Pribyl J, Skl&#xE1;dal P, Pe&#x161;l M, Caluori G, Pagliari S, Martino F, Maceckova Z, Hajduch M, Sanz-Garcia A, Pugno NM, Stokin GB and Forte G. YAP regulates cell mechanics by controlling focal adhesion assembly. Nat Commun 2017; 8: 15321.","journal-title":"Nat Commun"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Liu M, Zhang Y, Yang J, Zhan H, Zhou Z, Jiang Y, Shi X, Fan X, Zhang J, Luo W, Fung KA, Xu C, Bronze MS, Houchen CW and Li M. Zinc-dependent regulation of ZEB1 and YAP1 coactivation promotes epithelial-mesenchymal transition plasticity and metastasis in pancreatic cancer. Gastroenterology 2021; 160: 1771-1783, e1771.","DOI":"10.1053\/j.gastro.2020.12.077"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"5660","DOI":"10.1038\/ncomms6660","article-title":"Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis","volume":"5","author":"Liu","year":"2014","unstructured":"Liu Y, Lu X, Huang L, Wang W, Jiang G, Dean KC, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Darling DS, Postigo A and Dean DC. Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis. Nat Commun 2014; 5: 5660.","journal-title":"Nat Commun"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4161\/cbt.9.3.10749","article-title":"ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts","volume":"9","author":"Zhang","year":"2010","unstructured":"Zhang Y, Chen C, Yao Q and Li M. ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts. Cancer Biol Ther 2010; 9: 236-242.","journal-title":"Cancer Biol Ther"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Liu M, Zhang Y, Yang J, Cui X, Zhou Z, Zhan H, Ding K, Tian X, Yang Z, Fung KA, Edil BH, Postier RG, Bronze MS, Fernandez-Zapico ME, Stemmler MP, Brabletz T, Li YP, Houchen CW and Li M. ZIP4 increases expression of transcription factor ZEB1 to promote integrin &#x3B1;3&#x3B2;1 signaling and inhibit expression of the gemcitabine transporter ENT1 in pancreatic cancer cells. Gastroenterology 2020; 158: 679-692, e671.","DOI":"10.1053\/j.gastro.2019.10.038"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00280-011-1613-0","article-title":"A novel method for quantification of gemcitabine and its metabolites 2&#x2019;,2&#x2019;-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS\/MS: comparison with (19)F NMR spectroscopy","volume":"68","author":"Bapiro","year":"2011","unstructured":"Bapiro TE, Richards FM, Goldgraben MA, Olive KP, Madhu B, Frese KK, Cook N, Jacobetz MA, Smith DM, Tuveson DA, Griffiths JR and Jodrell DI. A novel method for quantification of gemcitabine and its metabolites 2&#x2019;,2&#x2019;-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC-MS\/MS: comparison with (19)F NMR spectroscopy. Cancer Chemother Pharmacol 2011; 68: 1243-1253.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10555-007-9044-4","article-title":"The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs","volume":"26","author":"Zhang","year":"2007","unstructured":"Zhang J, Visser F, King KM, Baldwin SA, Young JD and Cass CE. The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs. Cancer Metastasis Rev 2007; 26: 85-110.","journal-title":"Cancer Metastasis Rev"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1593\/neo.10576","article-title":"Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells","volume":"12","author":"Hagmann","year":"2010","unstructured":"Hagmann W, Jesnowski R and L&#xF6;hr JM. Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells. Neoplasia 2010; 12: 740-747.","journal-title":"Neoplasia"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1053\/j.gastro.2008.09.067","article-title":"Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer","volume":"136","author":"Farrell","year":"2009","unstructured":"Farrell JJ, Elsaleh H, Garcia M, Lai R, Ammar A, Regine WF, Abrams R, Benson AB, Macdonald J, Cass CE, Dicker AP and Mackey JR. Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. Gastroenterology 2009; 136: 187-195.","journal-title":"Gastroenterology"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"831","DOI":"10.15252\/emmm.201404396","article-title":"ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat","volume":"7","author":"Meidhof","year":"2015","unstructured":"Meidhof S, Brabletz S, Lehmann W, Preca BT, Mock K, Ruh M, Sch&#xFC;ler J, Berthold M, Weber A, Burk U, L&#xFC;bbert M, Puhr M, Culig Z, Wellner U, Keck T, Bronsert P, K&#xFC;sters S, Hopt UT, Stemmler MP and Brabletz T. ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Mol Med 2015; 7: 831-847.","journal-title":"EMBO Mol Med"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbrc.2018.09.061","article-title":"Integrin &#x3B2;1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110&#x3B2; signaling","volume":"505","author":"Yang","year":"2018","unstructured":"Yang D, Tang Y, Fu H, Xu J, Hu Z, Zhang Y and Cai Q. Integrin &#x3B2;1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110&#x3B2; signaling. Biochem Biophys Res Commun 2018; 505: 215-221.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.1038\/s41598-017-09946-z","article-title":"ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer","volume":"7","author":"Gharibi","year":"2017","unstructured":"Gharibi A, La Kim S, Molnar J, Brambilla D, Adamian Y, Hoover M, Hong J, Lin J, Wolfenden L and Kelber JA. ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer. Sci Rep 2017; 7: 10060.","journal-title":"Sci Rep"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S and Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489-495.","journal-title":"Lancet Oncol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1476-4598-2-36","article-title":"Cancer cachexia","volume":"2","author":"ME","year":"2003","unstructured":"Martignoni ME, Kunze P and Friess H. Cancer cachexia. Mol Cancer 2003; 2: 36.","journal-title":"Mol Cancer"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/mco.0000000000000272","article-title":"Diagnostic criteria for cancer cachexia: data versus dogma","volume":"19","author":"Martin","year":"2016","unstructured":"Martin L. Diagnostic criteria for cancer cachexia: data versus dogma. Curr Opin Clin Nutr Metab Care 2016; 19: 188-198.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"KC","year":"2012","unstructured":"Fearon KC, Glass DJ and Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 2012; 16: 153-166.","journal-title":"Cell Metab"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.advms.2013.11.001","article-title":"Anorexia-cachexia syndrome in pancreatic cancer: recent advances and new pharmacological approach","volume":"59","author":"Ronga","year":"2014","unstructured":"Ronga I, Gallucci F, Riccardi F and Uomo G. Anorexia-cachexia syndrome in pancreatic cancer: recent advances and new pharmacological approach. Adv Med Sci 2014; 59: 1-6.","journal-title":"Adv Med Sci"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC and Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers 2018; 4: 17105.","journal-title":"Nat Rev Dis Primers"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.276733.115","article-title":"Mechanisms of metabolic dysfunction in cancer-associated cachexia","volume":"30","author":"Petruzzelli","year":"2016","unstructured":"Petruzzelli M and Wagner EF. Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev 2016; 30: 489-501.","journal-title":"Genes Dev"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Yang J, Zhang Z, Zhang Y, Ni X, Zhang G, Cui X, Liu M, Xu C, Zhang Q, Zhu H, Yan J, Zhu VF, Luo Y, Hagan JP, Li Z, Fang J, Jatoi A, Fernandez-Zapico ME, Zheng L, Edil BH, Bronze MS, Houchen CW, Li YP and Li M. ZIP4 promotes muscle wasting and cachexia in mice with orthotopic pancreatic tumors by stimulating RAB27B-regulated release of extracellular vesicles from cancer cells. Gastroenterology 2019; 156: 722-734, e726.","DOI":"10.1053\/j.gastro.2018.10.026"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Zhou Z, Ren Y, Yang J, Liu M, Shi X, Luo W, Fung KM, Xu C, Bronze MS, Zhang Y, Houchen CW and Li M. Acetyl-Coenzyme A synthetase 2 potentiates macropinocytosis and muscle wasting through metabolic reprogramming in pancreatic cancer. Gastroenterology 2022; 163: 1281-1293, e1281.","DOI":"10.1053\/j.gastro.2022.06.058"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"26041","DOI":"10.18632\/oncotarget.4667","article-title":"ZIP4 silencing improves bone loss in pancreatic cancer","volume":"6","author":"Zhang","year":"2015","unstructured":"Zhang Q, Sun X, Yang J, Ding H, LeBrun D, Ding K, Houchen CW, Postier RG, Ambrose CG, Li Z, Bi X and Li M. ZIP4 silencing improves bone loss in pancreatic cancer. Oncotarget 2015; 6: 26041-26051.","journal-title":"Oncotarget"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.clnu.2024.04.012","article-title":"Serum trace elements during treatment in pancreatic cancer patients and their associations with cancer prognosis","volume":"43","author":"JA","year":"2024","unstructured":"Kim JA, Lee JK and Lee SY. Serum trace elements during treatment in pancreatic cancer patients and their associations with cancer prognosis. Clin Nutr 2024; 43: 1459-1472.","journal-title":"Clin Nutr"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW and Shroff RT. Pancreatic cancer. Lancet 2020; 395: 2008-2020.","journal-title":"Lancet"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"RL","year":"2019","unstructured":"Siegel RL, Miller KD and Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69: 7-34.","journal-title":"CA Cancer J Clin"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nrc3628","article-title":"Crossing the endothelial barrier during metastasis","volume":"13","author":"Reymond","year":"2013","unstructured":"Reymond N, d&#x2019;&#xC1;gua BB and Ridley AJ. Crossing the endothelial barrier during metastasis. Nat Rev Cancer 2013; 13: 858-870.","journal-title":"Nat Rev Cancer"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3390\/nu11102273","article-title":"Role of Zinc in immune system and anti-cancer defense mechanisms","volume":"11","author":"Skrajnowska","year":"2019","unstructured":"Skrajnowska D and Bobrowska-Korczak B. Role of Zinc in immune system and anti-cancer defense mechanisms. Nutrients 2019; 11: 2273.","journal-title":"Nutrients"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/antiox8060164","article-title":"Molecular mechanisms of Zinc as a pro-antioxidant mediator: clinical therapeutic implications","volume":"8","author":"Prasad","year":"2019","unstructured":"Prasad AS and Bao B. Molecular mechanisms of Zinc as a pro-antioxidant mediator: clinical therapeutic implications. Antioxidants (Basel) 2019; 8: 164.","journal-title":"Antioxidants (Basel)"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/jnci\/dji292","article-title":"Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study","volume":"97","author":"N&#xF6","year":"2005","unstructured":"N&#xF6;thlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE and Kolonel LN. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst 2005; 97: 1458-1465.","journal-title":"J Natl Cancer Inst"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7150\/ijbs.7401","article-title":"ZIP4, a novel determinant of tumor invasion in hepatocellular carcinoma, contributes to tumor recurrence after liver transplantation","volume":"10","author":"Xu","year":"2014","unstructured":"Xu X, Guo HJ, Xie HY, Li J, Zhuang RZ, Ling Q, Zhou L, Wei XY, Liu ZK, Ding SM, Chen KJ, Xu ZY and Zheng SS. ZIP4, a novel determinant of tumor invasion in hepatocellular carcinoma, contributes to tumor recurrence after liver transplantation. Int J Biol Sci 2014; 10: 245-256.","journal-title":"Int J Biol Sci"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.3390\/cancers12123692","article-title":"ZIP4 is a novel cancer stem cell marker in high-grade serous ovarian cancer","volume":"12","author":"Fan","year":"2020","unstructured":"Fan Q, Zhang W, Emerson RE and Xu Y. ZIP4 is a novel cancer stem cell marker in high-grade serous ovarian cancer. Cancers (Basel) 2020; 12: 3692.","journal-title":"Cancers (Basel)"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.3390\/cancers13153821","article-title":"A novel ZIP4-HDAC4-VEGFA axis in high-grade serous ovarian cancer","volume":"13","author":"Fan","year":"2021","unstructured":"Fan Q, Li L, Wang TL, Emerson RE and Xu Y. A novel ZIP4-HDAC4-VEGFA axis in high-grade serous ovarian cancer. Cancers (Basel) 2021; 13: 3821.","journal-title":"Cancers (Basel)"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/neuonc\/not042","article-title":"ZIP4 is a novel molecular marker for glioma","volume":"15","author":"Lin","year":"2013","unstructured":"Lin Y, Chen Y, Wang Y, Yang J, Zhu VF, Liu Y, Cui X, Chen L, Yan W, Jiang T, Hergenroeder GW, Fletcher SA, Levine JM, Kim DH, Tandon N, Zhu JJ and Li M. ZIP4 is a novel molecular marker for glioma. Neuro Oncol 2013; 15: 1008-1016.","journal-title":"Neuro Oncol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.2147\/CMAR.S282269","article-title":"Knockdown of SLC39A4 expression inhibits the proliferation and motility of gallbladder cancer cells and tumor formation in nude mice","volume":"13","author":"Li","year":"2021","unstructured":"Li M, Fan K, Zheng B, Zekria D, Suo T, Liu H, Shen S, Liu H and Ni X. Knockdown of SLC39A4 expression inhibits the proliferation and motility of gallbladder cancer cells and tumor formation in nude mice. Cancer Manag Res 2021; 13: 2235-2246.","journal-title":"Cancer Manag Res"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41419-019-1807-7","article-title":"Inhibition of ZIP4 reverses epithelial-to-mesenchymal transition and enhances the radiosensitivity in human nasopharyngeal carcinoma cells","volume":"10","author":"Zeng","year":"2019","unstructured":"Zeng Q, Liu YM, Liu J, Han J, Guo JX, Lu S, Huang XM, Yi P, Lang JY, Zhang P and Wang CT. Inhibition of ZIP4 reverses epithelial-to-mesenchymal transition and enhances the radiosensitivity in human nasopharyngeal carcinoma cells. Cell Death Dis 2019; 10: 588.","journal-title":"Cell Death Dis"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2021.08.025","article-title":"ZIP4 promotes non-small cell lung cancer metastasis by activating snail-N-cadherin signaling axis","volume":"521","author":"Jiang","year":"2021","unstructured":"Jiang Y, Zhan H, Zhang Y, Yang J, Liu M, Xu C, Fan X, Zhang J, Zhou Z, Shi X, Ramesh R and Li M. ZIP4 promotes non-small cell lung cancer metastasis by activating snail-N-cadherin signaling axis. Cancer Lett 2021; 521: 71-81.","journal-title":"Cancer Lett"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.urolonc.2010.11.010","article-title":"The role of zinc transporter ZIP4 in prostate carcinoma","volume":"30","author":"Chen","year":"2012","unstructured":"Chen QG, Zhang Z, Yang Q, Shan GY, Yu XY and Kong CZ. The role of zinc transporter ZIP4 in prostate carcinoma. Urol Oncol 2012; 30: 906-911.","journal-title":"Urol Oncol"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"9188","DOI":"10.3390\/ijms22179188","article-title":"Zinc favors triple-negative breast cancer&#x2019;s microenvironment modulation and cell plasticity","volume":"22","author":"Vogel-Gonz&#xE1","year":"2021","unstructured":"Vogel-Gonz&#xE1;lez M, Musa-Afaneh D, Rivera Gil P and Vicente R. Zinc favors triple-negative breast cancer&#x2019;s microenvironment modulation and cell plasticity. Int J Mol Sci 2021; 22: 9188.","journal-title":"Int J Mol Sci"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/9\/ajcr0157697.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:41Z","timestamp":1766023001000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/9\/ajcr0157697.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":84,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/avym3477","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}